{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:29:53Z","timestamp":1792074593270,"version":"4.4.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG072946"],"award-info":[{"award-number":["AG072946"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG075583"],"award-info":[{"award-number":["R01AG075583"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2R01AG039621"],"award-info":[{"award-number":["2R01AG039621"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"DOI":"10.1186\/s12987-024-00615-8","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T14:46:28Z","timestamp":1736433988000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Plasma S100\u03b2 is a predictor for pathology and cognitive decline in Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"22","author":[{"given":"Geetika","family":"Nehra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan J.","family":"Maloney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wijitra","family":"Chumboatong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin L.","family":"Abner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter T.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anika M. S.","family":"Hartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,9]]},"reference":[{"issue":"15","key":"615_CR1","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s40265-023-01938-w","volume":"83","author":"JL Cummings","year":"2023","unstructured":"Cummings JL, Osse AML, Kinney JW. Alzheimer\u2019s disease: novel targets and investigational drugs for disease modification. Drugs. 2023;83(15):1387\u2013408.","journal-title":"Drugs"},{"issue":"9","key":"615_CR2","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/s41582-021-00520-w","volume":"17","author":"H Hampel","year":"2021","unstructured":"Hampel H, Cummings J, Blennow K, Gao P, Jack CR Jr, Vergallo A. Developing the ATX(N) classification for use across the Alzheimer disease continuum. Nat Rev Neurol. 2021;17(9):580\u20139.","journal-title":"Nat Rev Neurol"},{"key":"615_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108119","volume":"234","author":"G Nehra","year":"2022","unstructured":"Nehra G, Bauer B, Hartz AMS. Blood-brain barrier leakage in Alzheimer\u2019s disease: from discovery to clinical relevance. Pharmacol Ther. 2022;234: 108119.","journal-title":"Pharmacol Ther"},{"issue":"2","key":"615_CR4","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3233\/JAD-122140","volume":"35","author":"SG Di Santo","year":"2013","unstructured":"Di Santo SG, Prinelli F, Adorni F, Caltagirone C, Musicco M. A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer\u2019s disease. J Alzheimers Dis. 2013;35(2):349\u201361.","journal-title":"J Alzheimers Dis"},{"issue":"7618","key":"615_CR5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature19323","volume":"537","author":"J Sevigny","year":"2016","unstructured":"Sevigny J, Chiao P, Bussiere T, Weinreb PH, Williams L, Maier M, et al. The antibody aducanumab reduces Abeta plaques in Alzheimer\u2019s disease. Nature. 2016;537(7618):50\u20136.","journal-title":"Nature"},{"issue":"1","key":"615_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in early Alzheimer\u2019s disease. N Engl J Med. 2023;388(1):9\u201321.","journal-title":"N Engl J Med"},{"issue":"2","key":"615_CR7","first-page":"197","volume":"9","author":"S Budd Haeberlein","year":"2022","unstructured":"Budd Haeberlein S, Aisen PS, Barkhof F, Chalkias S, Chen T, Cohen S, et al. Two randomized phase 3 studies of aducanumab in early Alzheimer\u2019s disease. J Prev Alzheimer Dis. 2022;9(2):197\u2013210.","journal-title":"J Prev Alzheimer Dis"},{"issue":"1","key":"615_CR8","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13195-021-00813-8","volume":"13","author":"CJ Swanson","year":"2021","unstructured":"Swanson CJ, Zhang Y, Dhadda S, Wang J, Kaplow J, Lai RYK, et al. A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer\u2019s disease with lecanemab, an anti-Abeta protofibril antibody. Alzheimers Res Ther. 2021;13(1):80.","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"615_CR9","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1093\/brain\/awad042","volume":"146","author":"CR Jack","year":"2023","unstructured":"Jack CR, Wiste HJ, Algeciras-Schimnich A, Figdore DJ, Schwarz CG, Lowe VJ, et al. Predicting amyloid PET and tau PET stages with plasma biomarkers. Brain. 2023;146(5):2029\u201344.","journal-title":"Brain"},{"issue":"6","key":"615_CR10","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1177\/0271678X20952012","volume":"41","author":"WJ Moon","year":"2021","unstructured":"Moon WJ, Lim C, Ha IH, Kim Y, Moon Y, Kim HJ, et al. Hippocampal blood-brain barrier permeability is related to the APOE4 mutation status of elderly individuals without dementia. J Cereb Blood Flow Metab. 2021;41(6):1351\u201361.","journal-title":"J Cereb Blood Flow Metab"},{"key":"615_CR11","doi-asserted-by":"publisher","first-page":"1111448","DOI":"10.3389\/fnagi.2023.1111448","volume":"15","author":"Y Uchida","year":"2023","unstructured":"Uchida Y, Kan H, Sakurai K, Oishi K, Matsukawa N. Contributions of blood-brain barrier imaging to neurovascular unit pathophysiology of Alzheimer\u2019s disease and related dementias. Front Aging Neurosci. 2023;15:1111448.","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"615_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3109\/09687688.2015.1023378","volume":"32","author":"BG Akkaya","year":"2015","unstructured":"Akkaya BG, Zolnerciks JK, Ritchie TK, Bauer B, Hartz AM, Sullivan JA, et al. The multidrug resistance pump ABCB1 is a substrate for the ubiquitin ligase NEDD4-1. Mol Membr Biol. 2015;32(2):39\u201345.","journal-title":"Mol Membr Biol"},{"issue":"3","key":"615_CR13","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1161\/STROKEAHA.122.040578","volume":"54","author":"AV Andjelkovic","year":"2023","unstructured":"Andjelkovic AV, Situ M, Citalan-Madrid AF, Stamatovic SM, Xiang J, Keep RF. Blood-brain barrier dysfunction in normal aging and neurodegeneration: mechanisms, impact, and treatments. Stroke. 2023;54(3):661\u201372.","journal-title":"Stroke"},{"issue":"1\u20134","key":"615_CR14","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1159\/000334916","volume":"10","author":"A Carrano","year":"2012","unstructured":"Carrano A, Hoozemans JJ, van der Vies SM, van Horssen J, de Vries HE, Rozemuller AJ. Neuroinflammation and blood-brain barrier changes in capillary amyloid angiopathy. Neurodegener Dis. 2012;10(1\u20134):329\u201331.","journal-title":"Neurodegener Dis"},{"key":"615_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010246","author":"AB Chai","year":"2020","unstructured":"Chai AB, Hartz AMS, Gao X, Yang A, Callaghan R, Gelissen IC. New evidence for P-gp-mediated export of amyloid-\u03b2 PEPTIDES in molecular, blood-brain barrier and neuronal models. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms22010246.","journal-title":"Int J Mol Sci"},{"key":"615_CR16","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3389\/fnagi.2018.00225","volume":"10","author":"J Lee","year":"2018","unstructured":"Lee J, Yanckello LM, Ma D, Hoffman JD, Parikh I, Thalman S, et al. Neuroimaging biomarkers of mTOR inhibition on vascular and metabolic functions in aging brain and Alzheimer\u2019s disease. Front Aging Neurosci. 2018;10:225.","journal-title":"Front Aging Neurosci"},{"key":"615_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.104834","volume":"139","author":"AL Lin","year":"2020","unstructured":"Lin AL, Parikh I, Yanckello LM, White RS, Hartz AMS, Taylor CE, et al. APOE genotype-dependent pharmacogenetic responses to rapamycin for preventing Alzheimer\u2019s disease. Neurobiol Dis. 2020;139: 104834.","journal-title":"Neurobiol Dis"},{"issue":"2","key":"615_CR18","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","volume":"25","author":"DA Nation","year":"2019","unstructured":"Nation DA, Sweeney MD, Montagne A, Sagare AP, D\u2019Orazio LM, Pachicano M, et al. Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat Med. 2019;25(2):270\u20136.","journal-title":"Nat Med"},{"issue":"1","key":"615_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.neulet.2011.09.049","volume":"505","author":"AP Viggars","year":"2011","unstructured":"Viggars AP, Wharton SB, Simpson JE, Matthews FE, Brayne C, Savva GM, et al. Alterations in the blood brain barrier in ageing cerebral cortex in relationship to Alzheimer-type pathology: a study in the MRC-CFAS population neuropathology cohort. Neurosci Lett. 2011;505(1):25\u201330.","journal-title":"Neurosci Lett"},{"issue":"2","key":"615_CR20","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1161\/STROKEAHA.111.627562","volume":"43","author":"AM Hartz","year":"2012","unstructured":"Hartz AM, Bauer B, Soldner EL, Wolf A, Boy S, Backhaus R, et al. Amyloid-\u03b2 contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy. Stroke. 2012;43(2):514\u201323.","journal-title":"Stroke"},{"issue":"5","key":"615_CR21","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/BF02334602","volume":"8","author":"AB Scheibel","year":"1987","unstructured":"Scheibel AB. Alterations of the cerebral capillary bed in the senile dementia of Alzheimer. Ital J Neurol Sci. 1987;8(5):457\u201363.","journal-title":"Ital J Neurol Sci"},{"issue":"3","key":"615_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12782","volume":"48","author":"C Kurz","year":"2022","unstructured":"Kurz C, Walker L, Rauchmann BS, Perneczky R. Dysfunction of the blood-brain barrier in Alzheimer\u2019s disease: evidence from human studies. Neuropathol Appl Neurobiol. 2022;48(3): e12782.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"6","key":"615_CR23","doi-asserted-by":"publisher","first-page":"724","DOI":"10.2174\/156720512801322591","volume":"9","author":"FA Schmitt","year":"2012","unstructured":"Schmitt FA, Nelson PT, Abner E, Scheff S, Jicha GA, Smith C, et al. University of Kentucky Sanders-brown healthy brain aging volunteers: donor characteristics, procedures and neuropathology. Curr Alzheimer Res. 2012;9(6):724\u201333.","journal-title":"Curr Alzheimer Res"},{"issue":"3","key":"615_CR24","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3233\/JAD-2011-101980","volume":"25","author":"EL Abner","year":"2011","unstructured":"Abner EL, Kryscio RJ, Schmitt FA, Santacruz KS, Jicha GA, Lin Y, et al. \u201cEnd-stage\u201d neurofibrillary tangle pathology in preclinical Alzheimer\u2019s disease: fact or fiction? J Alzheimers Dis. 2011;25(3):445\u201353.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"615_CR25","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.jneumeth.2008.09.008","volume":"176","author":"UT Byrne","year":"2009","unstructured":"Byrne UT, Ross JM, Faull RL, Dragunow M. High-throughput quantification of Alzheimer\u2019s disease pathological markers in the post-mortem human brain. J Neurosci Methods. 2009;176(2):298\u2013309.","journal-title":"J Neurosci Methods"},{"issue":"6","key":"615_CR26","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1365-2990.1989.tb01255.x","volume":"15","author":"C Lamy","year":"1989","unstructured":"Lamy C, Duyckaerts C, Delaere P, Payan C, Fermanian J, Poulain V, et al. Comparison of seven staining methods for senile plaques and neurofibrillary tangles in a prospective series of 15 elderly patients. Neuropathol Appl Neurobiol. 1989;15(6):563\u201378.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"615_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/NEN.0b013e3181919a48","volume":"68","author":"PT Nelson","year":"2009","unstructured":"Nelson PT, Braak H, Markesbery WR. Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship. J Neuropathol Exp Neurol. 2009;68(1):1\u201314.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"12","key":"615_CR28","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1097\/nen.0b013e31815c5efb","volume":"66","author":"PT Nelson","year":"2007","unstructured":"Nelson PT, Jicha GA, Schmitt FA, Liu H, Davis DG, Mendiondo MS, et al. Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles \u201cdo count\u201d when staging disease severity. J Neuropathol Exp Neurol. 2007;66(12):1136\u201346.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"615_CR29","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3109\/10520290903389445","volume":"85","author":"MR D'Andrea","year":"2010","unstructured":"D\u2019Andrea MR, Nagele RG. Morphologically distinct types of amyloid plaques point the way to a better understanding of Alzheimer\u2019s disease pathogenesis. Biotech Histochem. 2010;85(2):133\u201347.","journal-title":"Biotech Histochem"},{"issue":"10","key":"615_CR30","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s12264-022-00927-5","volume":"38","author":"F Liu","year":"2022","unstructured":"Liu F, Sun J, Wang X, Jin S, Sun F, Wang T, et al. Focal-type, but not diffuse-type, amyloid beta plaques are correlated with Alzheimer\u2019s neuropathology, cognitive dysfunction, and neuroinflammation in the human hippocampus. Neurosci Bull. 2022;38(10):1125\u201338.","journal-title":"Neurosci Bull"},{"issue":"1","key":"615_CR31","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3233\/JAD-180589","volume":"67","author":"AM Helman","year":"2019","unstructured":"Helman AM, Siever M, McCarty KL, Lott IT, Doran E, Abner EL, et al. Microbleeds and cerebral amyloid angiopathy in the brains of people with down syndrome with Alzheimer\u2019s disease. J Alzheimers Dis. 2019;67(1):103\u201312.","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"615_CR32","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1001\/archneur.57.6.869","volume":"57","author":"JM Olichney","year":"2000","unstructured":"Olichney JM, Hansen LA, Hofstetter CR, Lee JH, Katzman R, Thal LJ. Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4. Arch Neurol. 2000;57(6):869\u201374.","journal-title":"Arch Neurol"},{"issue":"5","key":"615_CR33","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/ana.410300503","volume":"30","author":"JP Vonsattel","year":"1991","unstructured":"Vonsattel JP, Myers RH, Hedley-Whyte ET, Ropper AH, Bird ED, Richardson EP Jr. Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol. 1991;30(5):637\u201349.","journal-title":"Ann Neurol"},{"issue":"4","key":"615_CR34","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/WAD.0000000000000279","volume":"32","author":"L Besser","year":"2018","unstructured":"Besser L, Kukull W, Knopman DS, Chui H, Galasko D, Weintraub S, et al. Version 3 of the national Alzheimer\u2019s coordinating center\u2019s uniform data set. Alzheimer Dis Assoc Disord. 2018;32(4):351\u20138.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"24","key":"615_CR35","doi-asserted-by":"publisher","first-page":"e2944","DOI":"10.1212\/WNL.0000000000012109","volume":"96","author":"B Bellaver","year":"2021","unstructured":"Bellaver B, Ferrari-Souza JP, Uglione da Ros L, Carter SF, Rodriguez-Vieitez E, Nordberg A, et al. Astrocyte biomarkers in Alzheimer disease: a systematic review and meta-analysis. Neurology. 2021;96(24):e2944\u201355.","journal-title":"Neurology"},{"key":"615_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/cells12091309","author":"KY Kim","year":"2023","unstructured":"Kim KY, Shin KY, Chang KA. GFAP as a potential biomarker for Alzheimer\u2019s disease: a systematic review and meta-analysis. Cells. 2023. https:\/\/doi.org\/10.3390\/cells12091309.","journal-title":"Cells"},{"issue":"3","key":"615_CR37","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1515\/CCLM.2011.083","volume":"49","author":"J Steiner","year":"2011","unstructured":"Steiner J, Bogerts B, Schroeter ML, Bernstein HG. S100B protein in neurodegenerative disorders. Clin Chem Lab Med. 2011;49(3):409\u201324.","journal-title":"Clin Chem Lab Med"},{"issue":"10","key":"615_CR38","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1007\/s11064-021-03256-7","volume":"46","author":"M Verkerke","year":"2021","unstructured":"Verkerke M, Hol EM, Middeldorp J. Physiological and pathological ageing of astrocytes in the human brain. Neurochem Res. 2021;46(10):2662\u201375.","journal-title":"Neurochem Res"},{"issue":"1","key":"615_CR39","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12753","volume":"48","author":"L Viejo","year":"2022","unstructured":"Viejo L, Noori A, Merrill E, Das S, Hyman BT, Serrano-Pozo A. Systematic review of human post-mortem immunohistochemical studies and bioinformatics analyses unveil the complexity of astrocyte reaction in Alzheimer\u2019s disease. Neuropathol Appl Neurobiol. 2022;48(1): e12753.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"12","key":"615_CR40","doi-asserted-by":"publisher","first-page":"14281","DOI":"10.1096\/fj.201901369RR","volume":"33","author":"AMS Hartz","year":"2019","unstructured":"Hartz AMS, Rempe RG, Soldner ELB, Pekcec A, Schlichtiger J, Kryscio R, et al. Cytosolic phospholipase A2 is a key regulator of blood-brain barrier function in epilepsy. Faseb J. 2019;33(12):14281\u201395.","journal-title":"Faseb J"},{"key":"615_CR41","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3389\/fnagi.2018.00186","volume":"10","author":"AMS Hartz","year":"2018","unstructured":"Hartz AMS, Zhong Y, Shen AN, Abner EL, Bauer B. Preventing P-gp ubiquitination lowers A\u03b2 brain levels in an Alzheimer\u2019s disease mouse model. Front Aging Neurosci. 2018;10:186.","journal-title":"Front Aging Neurosci"},{"issue":"12","key":"615_CR42","doi-asserted-by":"publisher","first-page":"13966","DOI":"10.1096\/fj.201901460RR","volume":"33","author":"ELB Soldner","year":"2019","unstructured":"Soldner ELB, Hartz AMS, Akanuma SI, Pekcec A, Doods H, Kryscio RJ, et al. Inhibition of human microsomal PGE2 synthase-1 reduces seizure-induced increases of P-glycoprotein expression and activity at the blood-brain barrier. Faseb J. 2019;33(12):13966\u201381.","journal-title":"Faseb J"},{"issue":"6","key":"615_CR43","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12942","volume":"49","author":"A Sziraki","year":"2023","unstructured":"Sziraki A, Zhong Y, Neltner AM, Niedowicz DM, Rogers CB, Wilcock DM, et al. A high-throughput single-cell RNA expression profiling method identifies human pericyte markers. Neuropathol Appl Neurobiol. 2023;49(6): e12942.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"615_CR44","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12987-021-00245-4","volume":"18","author":"Y Ding","year":"2021","unstructured":"Ding Y, Zhong Y, Baldeshwiler A, Abner EL, Bauer B, Hartz AMS. Protecting P-glycoprotein at the blood-brain barrier from degradation in an Alzheimer\u2019s disease mouse model. Fluids Barriers CNS. 2021;18(1):10.","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"615_CR45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12987-024-00531-x","volume":"21","author":"G Nehra","year":"2024","unstructured":"Nehra G, Promsan S, Yubolphan R, Chumboatong W, Vivithanaporn P, Maloney BJ, et al. Cognitive decline, Abeta pathology, and blood-brain barrier function in aged 5xFAD mice. Fluids Barriers CNS. 2024;21(1):29.","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"615_CR46","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12987-023-00470-z","volume":"20","author":"M Vulin","year":"2023","unstructured":"Vulin M, Zhong Y, Maloney BJ, Bauer B, Hartz AMS. Proteasome inhibition protects blood-brain barrier P-glycoprotein and lowers A\u03b2 brain levels in an Alzheimer\u2019s disease model. Fluids Barriers CNS. 2023;20(1):70.","journal-title":"Fluids Barriers CNS"},{"key":"615_CR47","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248\u201354.","journal-title":"Anal Biochem"},{"issue":"4","key":"615_CR48","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1021\/acs.molpharmaceut.6b00770","volume":"14","author":"AM Hartz","year":"2017","unstructured":"Hartz AM, Pekcec A, Soldner EL, Zhong Y, Schlichtiger J, Bauer B. P-gp protein expression and transport activity in rodent seizure models and human epilepsy. Mol Pharm. 2017;14(4):999\u20131011.","journal-title":"Mol Pharm"},{"issue":"6","key":"615_CR49","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1523\/JNEUROSCI.0350-15.2016","volume":"36","author":"AM Hartz","year":"2016","unstructured":"Hartz AM, Zhong Y, Wolf A, LeVine H 3rd, Miller DS, Bauer B. A\u03b240 reduces P-glycoprotein at the blood-brain barrier through the ubiquitin-proteasome pathway. J Neurosci. 2016;36(6):1930\u201341.","journal-title":"J Neurosci"},{"key":"615_CR50","unstructured":"Team RC. R: a language and environment for statistical computing, R foundation for statistical computing. https:\/\/www.r-projectorg\/."},{"key":"615_CR51","unstructured":"Fox J. Polycor: polychoric and polyserial correlations. 2022. https:\/\/www.cranr-projectorg\/web\/packages\/polycor\/indexhtml."},{"issue":"1\u20132","key":"615_CR52","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0166-4328(01)00297-2","volume":"125","author":"Y Benjamini","year":"2001","unstructured":"Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res. 2001;125(1\u20132):279\u201384.","journal-title":"Behav Brain Res"},{"issue":"1","key":"615_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v067.i01","volume":"67","author":"D Bates","year":"2015","unstructured":"Bates D, M\u00e4chler M, Bolker B, Walker S. Fitting linear mixed-effects models using lme4. J Stat Softw. 2015;67(1):1\u201348.","journal-title":"J Stat Softw"},{"key":"615_CR54","doi-asserted-by":"publisher","DOI":"10.1098\/rsif.2017.0213","author":"S Nakagawa","year":"2017","unstructured":"Nakagawa S, Johnson PCD, Schielzeth H. The coefficient of determination R2 and intra-class correlation coefficient from generalized linear mixed-effects models revisited and expanded. J R Soc Interfac. 2017. https:\/\/doi.org\/10.1098\/rsif.2017.0213.","journal-title":"J R Soc Interfac"},{"key":"615_CR55","unstructured":"Christensen RHB. Regression models for ordinal data: introducing R-package ordinal. 2022. https:\/\/www.CRAN.R-project.org\/package=ordinal."},{"key":"615_CR56","first-page":"488","volume-title":"Model selection and multimodel inference: a practical information-theoretic approach","author":"KP Burnham","year":"2002","unstructured":"Burnham KP, Anderson DR. Model selection and multimodel inference: a practical information-theoretic approach. 2nd ed. New York: Springer; 2002. p. 488.","edition":"2"},{"issue":"3","key":"615_CR57","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1093\/biomet\/78.3.691","volume":"78","author":"NJD Nagelkerke","year":"1991","unstructured":"Nagelkerke NJD. A note on a general definition of the coefficient of determination. Biometrika. 1991;78(3):691\u20132.","journal-title":"Biometrika"},{"issue":"4","key":"615_CR58","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1198\/tast.2009.08210","volume":"63","author":"T Tjur","year":"2009","unstructured":"Tjur T. Coefficients of determination in logistic regression models\u2014a new proposal: the coefficient of discrimination. Am Stat. 2009;63(4):366\u201372.","journal-title":"Am Stat"},{"issue":"4","key":"615_CR59","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1037\/1082-989X.8.4.434","volume":"8","author":"S Olejnik","year":"2003","unstructured":"Olejnik S, Algina J. Generalized eta and omega squared statistics: measures of effect size for some common research designs. Psychol Method. 2003;8(4):434\u201347.","journal-title":"Psychol Method"},{"issue":"2","key":"615_CR60","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/01.JGP.0000192478.82189.a8","volume":"14","author":"R Perneczky","year":"2006","unstructured":"Perneczky R, Wagenpfeil S, Komossa K, Grimmer T, Diehl J, Kurz A. Mapping scores onto stages: mini-mental state examination and clinical dementia rating. Am J Geriatr Psychiatry. 2006;14(2):139\u201344.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"10","key":"615_CR61","doi-asserted-by":"publisher","first-page":"4314","DOI":"10.1038\/s41380-022-01675-8","volume":"27","author":"AA Tsiknia","year":"2022","unstructured":"Tsiknia AA, Edland SD, Sundermann EE, Reas ET, Brewer JB, Galasko D, et al. Sex differences in plasma p-tau181 associations with Alzheimer\u2019s disease biomarkers, cognitive decline, and clinical progression. Mol Psychiatry. 2022;27(10):4314\u201322.","journal-title":"Mol Psychiatry"},{"key":"615_CR62","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1742-2094-5-9","volume":"5","author":"DA Loeffler","year":"2008","unstructured":"Loeffler DA, Camp DM, Bennett DA. Plaque complement activation and cognitive loss in Alzheimer\u2019s disease. J Neuroinflammation. 2008;5:9.","journal-title":"J Neuroinflammation"},{"issue":"9\u201310","key":"615_CR63","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1038\/sj.bjc.6690245","volume":"79","author":"CM Ferrier","year":"1999","unstructured":"Ferrier CM, de Witte HH, Straatman H, van Tienoven DH, van Geloof WL, Rietveld FJ, et al. Comparison of immunohistochemistry with immunoassay (ELISA) for the detection of components of the plasminogen activation system in human tumour tissue. Br J Cancer. 1999;79(9\u201310):1534\u201341.","journal-title":"Br J Cancer"},{"issue":"5","key":"615_CR64","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s00401-016-1560-2","volume":"131","author":"M Merlini","year":"2016","unstructured":"Merlini M, Wanner D, Nitsch RM. Tau pathology-dependent remodelling of cerebral arteries precedes Alzheimer\u2019s disease-related microvascular cerebral amyloid angiopathy. Acta Neuropathol. 2016;131(5):737\u201352.","journal-title":"Acta Neuropathol"},{"issue":"3","key":"615_CR65","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1161\/STROKEAHA.107.493429","volume":"39","author":"EG Stopa","year":"2008","unstructured":"Stopa EG, Butala P, Salloway S, Johanson CE, Gonzalez L, Tavares R, et al. Cerebral cortical arteriolar angiopathy, vascular beta-amyloid, smooth muscle actin, Braak stage, and APOE genotype. Stroke. 2008;39(3):814\u201321.","journal-title":"Stroke"},{"issue":"3","key":"615_CR66","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/nan.12085","volume":"40","author":"MJ Burke","year":"2014","unstructured":"Burke MJ, Nelson L, Slade JY, Oakley AE, Khundakar AA, Kalaria RN. Morphometry of the hippocampal microvasculature in post-stroke and age-related dementias. Neuropathol Appl Neurobiol. 2014;40(3):284\u201395.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"615_CR67","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40478-019-0666-x","volume":"7","author":"Y Hase","year":"2019","unstructured":"Hase Y, Ding R, Harrison G, Hawthorne E, King A, Gettings S, et al. White matter capillaries in vascular and neurodegenerative dementias. Acta Neuropathol Commun. 2019;7(1):16.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"615_CR68","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12987-020-00219-y","volume":"17","author":"M Damodarasamy","year":"2020","unstructured":"Damodarasamy M, Vernon RB, Pathan JL, Keene CD, Day AJ, Banks WA, et al. The microvascular extracellular matrix in brains with Alzheimer\u2019s disease neuropathologic change (ADNC) and cerebral amyloid angiopathy (CAA). Fluid Barriers CNS. 2020;17(1):60.","journal-title":"Fluid Barriers CNS"},{"issue":"5","key":"615_CR69","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nrn.2018.13","volume":"19","author":"MA Petersen","year":"2018","unstructured":"Petersen MA, Ryu JK, Akassoglou K. Fibrinogen in neurological diseases: mechanisms, imaging and therapeutics. Nat Rev Neurosci. 2018;19(5):283\u2013301.","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"615_CR70","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.neurobiolaging.2008.05.015","volume":"31","author":"JE Simpson","year":"2010","unstructured":"Simpson JE, Ince PG, Lace G, Forster G, Shaw PJ, Matthews F, et al. Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain. Neurobiol Aging. 2010;31(4):578\u201390.","journal-title":"Neurobiol Aging"},{"key":"615_CR71","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1742-2094-7-6","volume":"7","author":"ML Chaves","year":"2010","unstructured":"Chaves ML, Camozzato AL, Ferreira ED, Piazenski I, Kochhann R, Dall\u2019Igna O, et al. Serum levels of S100B and NSE proteins in Alzheimer\u2019s disease patients. J Neuroinflammation. 2010;7:6.","journal-title":"J Neuroinflammation"},{"issue":"1\u20132","key":"615_CR72","first-page":"43","volume":"183","author":"L Parnetti","year":"1995","unstructured":"Parnetti L, Palumbo B, Cardinali L, Loreti F, Chionne F, Cecchetti R, et al. Cerebrospinal fluid neuron-specific enolase in Alzheimer\u2019s disease and vascular dementia. Neurosci Lett. 1995;183(1\u20132):43\u20135.","journal-title":"Neurosci Lett"},{"key":"615_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnagi.2011.00001","volume":"3","author":"C Rosen","year":"2011","unstructured":"Rosen C, Mattsson N, Johansson PM, Andreasson U, Wallin A, Hansson O, et al. Discriminatory analysis of biochip-derived protein patterns in CSF and plasma in neurodegenerative diseases. Front Aging Neurosci. 2011;3:1.","journal-title":"Front Aging Neurosci"},{"issue":"9","key":"615_CR74","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1177\/0271678X16655551","volume":"36","author":"RG Rempe","year":"2016","unstructured":"Rempe RG, Hartz AMS, Bauer B. Matrix metalloproteinases in the brain and blood-brain barrier: versatile breakers and makers. J Cereb Blood Flow Metab. 2016;36(9):1481\u2013507.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"18","key":"615_CR75","doi-asserted-by":"publisher","first-page":"4301","DOI":"10.1523\/JNEUROSCI.2751-17.2018","volume":"38","author":"RG Rempe","year":"2018","unstructured":"Rempe RG, Hartz AMS, Soldner ELB, Sokola BS, Alluri SR, Abner EL, et al. Matrix metalloproteinase-mediated blood-brain barrier dysfunction in epilepsy. J Neurosci. 2018;38(18):4301\u201315.","journal-title":"J Neurosci"},{"key":"615_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.116989","volume":"416","author":"K Abe","year":"2020","unstructured":"Abe K, Chiba Y, Hattori S, Yoshimi A, Asami T, Katsuse O, et al. Influence of plasma matrix metalloproteinase levels on longitudinal changes in Alzheimer\u2019s disease (AD) biomarkers and cognitive function in patients with mild cognitive impairment due to AD registered in the Alzheimer\u2019s disease neuroimaging initiative database. J Neurol Sci. 2020;416: 116989.","journal-title":"J Neurol Sci"},{"key":"615_CR77","doi-asserted-by":"publisher","first-page":"153331752091871","DOI":"10.1177\/1533317520918719","volume":"35","author":"JS Benoit","year":"2020","unstructured":"Benoit JS, Chan W, Piller L, Doody R. Longitudinal sensitivity of Alzheimer\u2019s disease severity staging. Am J Alzheimers Dis Other Demen. 2020;35:1533317520918719.","journal-title":"Am J Alzheimers Dis Other Demen"},{"issue":"1","key":"615_CR78","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3233\/JAD-180970","volume":"67","author":"MF Iulita","year":"2019","unstructured":"Iulita MF, Ganesh A, Pentz R, Flores Aguilar L, Gubert P, Ducatenzeiler A, et al. Identification and preliminary validation of a plasma profile associated with cognitive decline in dementia and at-risk individuals: a retrospective cohort analysis. J Alzheimers Dis. 2019;67(1):327\u201341.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"615_CR79","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s40478-019-0795-2","volume":"7","author":"CD Whelan","year":"2019","unstructured":"Whelan CD, Mattsson N, Nagle MW, Vijayaraghavan S, Hyde C, Janelidze S, et al. Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer\u2019s disease. Acta Neuropathol Commun. 2019;7(1):169.","journal-title":"Acta Neuropathol Commun"},{"issue":"15","key":"615_CR80","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1097\/WNR.0000000000001952","volume":"34","author":"J Liu","year":"2023","unstructured":"Liu J, Li X, Qu J. Plasma MMP-9\/TIMP-1 ratio serves as a novel potential biomarker in Alzheimer\u2019s disease. NeuroReport. 2023;34(15):767\u201372.","journal-title":"NeuroReport"},{"key":"615_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2022.136799","volume":"786","author":"S Koca","year":"2022","unstructured":"Koca S, Kiris I, Sahin S, Cinar N, Karsidag S, Hanagasi HA, et al. Decreased levels of cytokines implicate altered immune response in plasma of moderate-stage Alzheimer\u2019s disease patients. Neurosci Lett. 2022;786: 136799.","journal-title":"Neurosci Lett"},{"issue":"3","key":"615_CR82","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.3233\/JAD-180752","volume":"66","author":"G Tuna","year":"2018","unstructured":"Tuna G, Yener GG, Oktay G, \u0130\u015flekel GH, K\u0130rkal\u0130 FG. Evaluation of matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) and their tissue inhibitors (TIMP-1 and TIMP-2) in plasma from patients with neurodegenerative dementia. J Alzheimers Dis. 2018;66(3):1265\u201373.","journal-title":"J Alzheimers Dis"},{"key":"615_CR83","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-024-04315-0","author":"D Radosinska","year":"2024","unstructured":"Radosinska D, Radosinska J. The link between matrix metalloproteinases and Alzheimer\u2019s disease pathophysiology. Mol Neurobiol. 2024. https:\/\/doi.org\/10.1007\/s12035-024-04315-0.","journal-title":"Mol Neurobiol"},{"issue":"12","key":"615_CR84","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.2174\/1567205018666210119145104","volume":"17","author":"JR Chaudhuri","year":"2020","unstructured":"Chaudhuri JR, Mridula KR, Rathnakishore C, Anamika A, Samala NR, Balaraju B, et al. Association serum S100B protein in Alzheimer\u2019s disease: a case control study from South India. Curr Alzheimer Res. 2020;17(12):1095\u2013101.","journal-title":"Curr Alzheimer Res"},{"issue":"6","key":"615_CR85","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/S1734-1140(12)70940-4","volume":"64","author":"M Kaci\u0144ski","year":"2012","unstructured":"Kaci\u0144ski M, Budziszewska B, Laso\u0144 W, Zaj\u0105c A, Skowronek-Ba\u0142a B, Le\u015bkiewicz M, et al. Level of S100B protein, neuron specific enolase, orexin A, adiponectin and insulin-like growth factor in serum of pediatric patients suffering from sleep disorders with or without epilepsy. Pharmacol Rep. 2012;64(6):1427\u201333.","journal-title":"Pharmacol Rep"},{"key":"615_CR86","doi-asserted-by":"publisher","DOI":"10.6402\/jpp.2019.2.04","author":"A Lasek-Bal","year":"2019","unstructured":"Lasek-Bal A, Jedrzejowska-Szypulka H, Student S, Warsz-Wianecka A, Zareba K, Puz P, et al. The importance of selected markers of inflammation and blood-brain barrier damage for short-term ischemic stroke prognosis. J Physiol Pharmacol. 2019. https:\/\/doi.org\/10.6402\/jpp.2019.2.04.","journal-title":"J Physiol Pharmacol"},{"issue":"15","key":"615_CR87","doi-asserted-by":"publisher","first-page":"4758","DOI":"10.1016\/j.jprot.2012.01.033","volume":"75","author":"J Montaner","year":"2012","unstructured":"Montaner J, Mendioroz M, Delgado P, Garc\u00eda-Berrocoso T, Giralt D, Merino C, et al. Differentiating ischemic from hemorrhagic stroke using plasma biomarkers: the S100B\/RAGE pathway. J Proteomics. 2012;75(15):4758\u201365.","journal-title":"J Proteomics"},{"issue":"5","key":"615_CR88","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.21873\/invivo.12075","volume":"34","author":"J Onatsu","year":"2020","unstructured":"Onatsu J, Vanninen R, J\u00e4k\u00e4l\u00e4 P, Mustonen P, Pulkki K, Korhonen M, et al. Tau, S100B and NSE as blood biomarkers in acute cerebrovascular events. In Vivo. 2020;34(5):2577\u201386.","journal-title":"In Vivo"},{"issue":"1","key":"615_CR89","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12868-023-00807-2","volume":"24","author":"T Abboud","year":"2023","unstructured":"Abboud T, Rohde V, Mielke D. Mini review: current status and perspective of S100B protein as a biomarker in daily clinical practice for diagnosis and prognosticating of clinical outcome in patients with neurological diseases with focus on acute brain injury. BMC Neurosci. 2023;24(1):38.","journal-title":"BMC Neurosci"},{"key":"615_CR90","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci13091334","author":"T Kozlowski","year":"2023","unstructured":"Kozlowski T, Bargiel W, Grabarczyk M, Skibinska M. Peripheral S100B protein levels in five major psychiatric disorders: a systematic review. Brain Sci. 2023. https:\/\/doi.org\/10.3390\/brainsci13091334.","journal-title":"Brain Sci"},{"issue":"4","key":"615_CR91","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s00018-020-03673-x","volume":"78","author":"E Angelopoulou","year":"2021","unstructured":"Angelopoulou E, Paudel YN, Piperi C. Emerging role of S100B protein implication in Parkinson\u2019s disease pathogenesis. Cell Mol Life Sci. 2021;78(4):1445\u201353.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"615_CR92","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12883-022-02730-1","volume":"22","author":"MC Cao","year":"2022","unstructured":"Cao MC, Cawston EE, Chen G, Brooks C, Douwes J, McLean D, et al. Serum biomarkers of neuroinflammation and blood-brain barrier leakage in amyotrophic lateral sclerosis. BMC Neurol. 2022;22(1):216.","journal-title":"BMC Neurol"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-024-00615-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12987-024-00615-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-024-00615-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T16:03:04Z","timestamp":1736438584000},"score":1,"resource":{"primary":{"URL":"https:\/\/fluidsbarrierscns.biomedcentral.com\/articles\/10.1186\/s12987-024-00615-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,9]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["615"],"URL":"https:\/\/doi.org\/10.1186\/s12987-024-00615-8","relation":{},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,9]]},"assertion":[{"value":"14 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Human Research\/Institutional Review Board (IRB) at the University of Kentucky (#B18-3115-M4) approved all experiments involving human tissue samples.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}